Epidemiology of Hepatitis C in Iran and the World.
Shiraz E-Medical Journal: 10 (4); 162-72
October 1, 2009
Article Type: Research Article
March 16, 2009
April 23, 2009
F. Epidemiology of Hepatitis C in Iran and the World.,
Shiraz E-Med J.
Online ahead of Print
Hepatitis C virus (HCV) infection creates a significant burden to health care system. The
epidemiological characteristics and risk factors for transmission vary across countries. A
literature review of published scientific reports on HCV epidemiology in Iran and summarize
of findings of some countries was performed. Prevalence of hepatitis C in Iran ranges from
0.5% to 0.97% in blood donors, 19.3% in patients with thalassemia, 19.6% in patients on
maintenance hemodialysis, 31.5% of drug abuser inmates in a prison of Hamadan, 45.4% of
inmates and 88.9% of intravenous drug abusers of a prison in Guilan were HCV antibody
positive. The risk of infection related to injection drug use and health care serving are the
most important for still growing number of infected persons. Expansion of harm-reducing
interventions for drug users, and educating preventive programs in targeted high-risk behaviors
populations will improve infection spread in our country. Design appropriate public health
strategies by involvement of regional health agencies for education, supervising addiction
control and establish policies for the appropriate use of injections, sterile principles in healthcare-
related procedures, and improvement in blood transfusion safety in countries with high
drug trafficking and insufficient health and social resources is needed. Control of HCV transmission
requires continuous monitoring, surveillance and prevention.
© 2009, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.